ACEI	Angiotensin-Converting Enzyme Inhibitor
AF	Atrial Fibrillation
AUC	Area Under the Curve
ARB	Angiotensin II Receptor Blocker
BB	Beta Blockers
BMI	Body Mass Index
CABG	Coronary Artery Bypass Grafting
CaB	Calcium Blockers
Ca-blocker	Calcium Channel Blocker
CAD	Coronary Artery Disease
CCS	Chronic Coronary Syndrome
cm3	Cubic Centimetres
CBA	Cryoballoon Ablation
CI	Confidence Interval
COPD	Chronic Obstructive Pulmonary Disease
CRP	C-Reactive Protein
CT	Computed Tomography
DPP4	Dipeptidyl Peptidase-4
EAT	Epicardial Adipose Tissue
ECG	Electrocardiogram
FDR	False Discovery Rate
GFR	Glomerular Filtration Rate
GIP	Glucose-Dependent Insulinotropic Polypeptide
GLP-1	Glucagon-Like Peptide-1
GLP1ra	Glucagon-Like Peptide-1 Receptor Agonist
HF	Heart Failure
HFpEF	Heart Failure with Preserved Ejection Fraction
HFrEF	Heart Failure with Reduced Ejection Fraction
HU	Hounsfield Units
IQR,	Interquartile Range
LA	Left Atrium
LA-EAT	Left Atrium Epicardial Adipose Tissue
LAA	Left Atrial Appendage
LVEF	Left Ventricular Ejection Fraction
MI	Myocardial Infarction
MRA	Mineralocorticoid Receptor Antagonist
NOAC	Non-Vitamin K Antagonist Oral Anticoagulant
OBS	Obstructive Sleep Apnea
OR	Odds Ratio
OSA	Obstructive Sleep Apnea
PCI	Percutaneous Coronary Intervention
PET	Positron Emission Tomography
PersAF	Persistent Atrial Fibrillation
PFA	Pulsed Field Ablation
PVAT	Perivascular Adipose Tissue
PVI	Pulmonary Vein Isolation
RCT	Randomized Controlled Trial
ROC	Receiver Operating Characteristic
SD	Standard Deviation
SGLT2i	Sodium-Glucose Cotransporter-2 Inhibitor
T2D	Type 2 Diabetes
Total-EAT	Total Epicardial Adipose Tissue
TSH	Thyroid-Stimulating Hormone
VKA	Vitamin K Antagonist